Response: the neurobiological model in community treatment programs by Brewster, Tom et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Psychiatry Publications and Presentations Psychiatry 
2002-7 
Response: the neurobiological model in community treatment 
programs 
Tom Brewster 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/psych_pp 
 Part of the Psychiatry Commons 
Repository Citation 
Brewster T, Farentinos C, Ziedonis DM. (2002). Response: the neurobiological model in community 
treatment programs. Psychiatry Publications and Presentations. Retrieved from 
https://escholarship.umassmed.edu/psych_pp/182 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Psychiatry Publications 
and Presentations by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
R E S E A R C H  R E V I E W S — T H E  N E U R O B I O L O G Y  O F  O P I O I D  D E P E N D E N C E  •  2 1  
RESPONSE: THE NEUROBIOLOGICAL MODEL IN 
COMMUNITY TREATMENT PROGRAMS 
Tom Brewster, L.C.S.W., Chris Farentinos, M.D., and Douglas Ziedonis, M.D. 
Chris Farentinos: This is very important information 
for patients and counselors to have. Patients can under-
stand their reactions in terms of, ‘By taking this 
drug I stimulated my brain so much I’ve kind of extin-
guished its ability to produce certain neurotransmit-
ters, and once I stop taking the drug, dysphoria will 
arise and that creates a cycle of addiction.’ And the 
counselor can have more empathy for the client: It’s 
not that the clients are not trying to get better or that 
they are bad people, but they feel so bad after they stop 
using the drug that they have to go back. There is also 
a neurobiological connection to impulsivity and per-
sonality disorders, so the whole thing fits together. 
Doug Ziedonis: From a pragmatic point of view, this 
kind of article is useful for stigma-busting with legis-
latures, since they don’t want to pay for habits or 
choices. They want to pay only in cases of medical 
necessity. 
The recovery community agrees with the disease 
concept of addiction. Most of the recovery models 
people use when working with addicted patients use 
some type of bio-psycho-social-spiritual matrix. The 
biological part is considered most important in early 
stages of recovery, maybe during the first year, because 
the patient has to deal with acute withdrawal, depend-
ence, and then protracted withdrawal. 
Where the recovery and medical communities 
often don’t see eye to eye is when the disease concept 
gets translated into a rationale for using medication, 
whether it is in the case of dual-diagnosis patients or 
even the use of naltrexone to treat opiate addiction. 
Naltrexone is a great medication; it can be very use-
ful in treating impaired professionals. But if you 
survey average community treatment programs, hardly 
any patients are on naltrexone. Methadone is its 
own medical model system that doesn’t always link 
well with places that use the abstinence model. I have 
worked at abstinence programs and have worked at 
Yale as medical director of a methadone program. I 
favor the use of methadone as part of a treatment con-
tinuum. 
Tom Brewster: Therapeutic communities have long 
been the most resistant single group to the use of med-
ications for opiate abuse treatment. I think there has 
been a movement among providers to utilize methadone 
more in our therapeutic communities. There certainly 
has been in my community. We actively maintain 
patients on the medication and have trained our coun-
selors. Our recovering counselors are abstinence-
oriented individuals: they don’t drink and they cer-
tainly aren’t using illicit substances. They generally 
challenge any form of medication, particularly anal-
gesic medication, even when it should be legitimately 
used for pain reduction after surgery and so forth. But 
our program has embraced methadone despite this 
resistance, because of the biological connection described 
by Kosten and George. 
The information about biology and about med-
ications is useful for patients who are asking to be taken 
off methadone. Patients come to me and say, ‘I want 
to detox. Methadone is not good. It is a weakness. My 
wife wants me off of it, my employer wants me off, 
society wants me off, my probation officer wants me 
off.’ Corrections workers press patients to feel guilty 
about taking a narcotic medicine. They don’t believe 
in it. We resist this pressure because we know better. 
The relapse rate of those who get off methadone main-
tenance is perilously high. We strongly discourage peo-
ple from going off the medicine.& 
